Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

The predictive value of risk indices for cardiac complications in living donor liver transplantation.

Canbolat IP, Erdogan Y, Adali G, Kaplan O, Dayangac M, Yuzer Y, Tokat Y.

Bratisl Lek Listy. 2018;119(5):289-293. doi: 10.4149/BLL_2018_054.

PMID:
29749243
2.

HCC with low- and normal-serum alpha-fetoprotein levels.

Carr BI, Akkiz H, Üsküdar O, Yalçın K, Guerra V, Kuran S, Karaoğullarından Ü, Altıntaş E, Özakyol A, Tokmak S, Ballı T, Yücesoy M, Bahçeci Hİ, Ülkü A, Akçam T, Polat KY, Ekinci N, Şimşek H, Örmeci N, Sonsuz A, Demir M, Kılıç M, Uygun A, Demir A, Delik A, Arslan B, Doran F, Yilmaz S, Tokat Y.

Clin Pract (Lond). 2018;15(1):453-464. doi: 10.4172/clinical-practice.1000393.

3.

Diagnostic performances of intravoxel incoherent motion and conventional diffusion-weighted imaging in the differential diagnosis of benign and malignant portal vein thrombus.

Aumann EK, Server S, Koyuncu Sokmen B, Oz A, Namal E, Gurcan NI, Balci NC, Tokat Y.

Abdom Radiol (NY). 2018 Feb 7. doi: 10.1007/s00261-018-1467-6. [Epub ahead of print]

PMID:
29411058
4.

Living Donor Liver Transplantation.

Bozkurt B, Dayangac M, Tokat Y.

Chirurgia (Bucur). 2017 May-Jun;112(3):217-228. doi: 10.21614/chirurgia.112.3.217. Review.

5.

Liver Transplantation in a Patient with Acquired Dysfibrinogenemia Who Presented with Subdural Hematoma: A Case Report.

Acar Ş, Güngör G, Dayangaç M, Diz-Küçükkaya R, Tokat Y, Akyıldız M.

Turk J Haematol. 2017 Dec 1;34(4):356-357. doi: 10.4274/tjh.2017.0045. Epub 2016 Jun 7. No abstract available.

6.

Graft-to-recipient weight ratio threshold adjusted to the model for end-stage liver disease score for living donor liver transplantation.

Alim A, Erdogan Y, Yuzer Y, Tokat Y, Oezcelik A.

Liver Transpl. 2016 Dec;22(12):1643-1648. doi: 10.1002/lt.24523.

7.

Liver transplantation for homozygote familial hypercholesterolemia: the only curative treatment.

Alim A, Tokat Y, Erdogan Y, Gokkaya Z, Dayangac M, Yuzer Y, Oezcelik A.

Pediatr Transplant. 2016 Dec;20(8):1060-1064. doi: 10.1111/petr.12763. Epub 2016 Jul 20.

PMID:
27435024
8.

The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence.

Idilman R, Akyildiz M, Keskin O, Gungor G, Yilmaz TU, Kalkan C, Dayangac M, Cinar K, Balci D, Hazinedaroglu S, Tokat Y.

Clin Transplant. 2016 Oct;30(10):1216-1221. doi: 10.1111/ctr.12804. Epub 2016 Aug 8.

PMID:
27409074
9.

The evolution of anterior sector venous drainage in right lobe living donor liver transplantation: does one technique fit all?

Dayangac M, Tokat Y.

Hepatobiliary Surg Nutr. 2016 Apr;5(2):151-8. doi: 10.3978/j.issn.2304-3881.2015.08.01. Review.

10.

Living Donor Liver Transplantation Outcomes for Hepatocellular Carcinoma Beyond Milan or UCSF Criteria.

Gunay Y, Guler N, Yaprak O, Dayangac M, Akyildiz M, Altaca G, Yuzer Y, Tokat Y.

Indian J Surg. 2015 Dec;77(Suppl 3):950-6. doi: 10.1007/s12262-014-1078-6. Epub 2014 Apr 24.

11.

Authors' reply.

Arat N, Akyıldız M, Tellioğlu G, Tokat Y.

Turk Kardiyol Dern Ars. 2015 Sep;43(6):586-7. doi: 10.5543/tkda.2015.. No abstract available.

12.

Living donor right lobe liver transplantation as a treatment for hepatic alveolar echinococcosis: report of three cases.

Demirbas T, Akyildiz M, Dayangac M, Yaprak O, Dogusoy G, Bassullu N, Yuzer Y, Tokat Y.

Hepatogastroenterology. 2015 Jan-Feb;62(137):93-7.

PMID:
25911875
13.

Cardiac involvement of primary hyperoxaluria accompanied by non-compaction cardiomyopathy and patent ductus arteriosus.

Arat N, Akyıldız M, Tellioğlu G, Tokat Y.

Turk Kardiyol Dern Ars. 2015 Apr;43(3):288-91. doi: 10.5543/tkda.2015.46026.

14.

Major complications of adult right lobe living liver donors.

Guler N, Yaprak O, Gunay Y, Dayangac M, Akyildiz M, Yuzer F, Yuzer Y, Tokat Y.

Hepatobiliary Pancreat Dis Int. 2015 Apr;14(2):150-6.

PMID:
25865687
15.

Living Donor Liver Transplantation in Patients 70 Years or Older.

Oezcelik A, Dayangac M, Guler N, Yaprak O, Erdogan Y, Akyildiz M, Sevdik Z, Yuzer Y, Tokat Y.

Transplantation. 2015 Jul;99(7):1436-40. doi: 10.1097/TP.0000000000000524.

PMID:
25606791
16.

Management of patients with recurrent hepatocellular carcinoma following living donor liver transplantation: a single center experience.

Gunay Y, Guler N, Akyildiz M, Yaprak O, Dayangac M, Yuzer Y, Tokat Y.

Gulf J Oncolog. 2014 Jan;1(15):12-8.

PMID:
24610283
17.

Glasgow coma scale and APACHE-II scores affect the liver transplantation outcomes in patients with acute liver failure.

Guler N, Unalp O, Guler A, Yaprak O, Dayangac M, Sozbilen M, Akyildiz M, Tokat Y.

Hepatobiliary Pancreat Dis Int. 2013 Dec;12(6):589-93.

PMID:
24322743
18.

Anatomical variations of donor portal vein in right lobe living donor liver transplantation: the safe use of variant portal veins.

Guler N, Dayangac M, Yaprak O, Akyildiz M, Gunay Y, Taskesen F, Tabandeh B, Bulutcu F, Yuzer Y, Tokat Y.

Transpl Int. 2013 Dec;26(12):1191-7. doi: 10.1111/tri.12190. Epub 2013 Oct 15.

19.

Living donor liver transplantation for obese patients: challenges and outcomes.

Gunay Y, Guler N, Dayangac M, Taskesen F, Yaprak O, Emek E, Akyildiz M, Altaca G, Yuzer Y, Tokat Y.

Liver Transpl. 2014 Mar;20(3):311-22. doi: 10.1002/lt.23794. Epub 2014 Jan 13.

20.

Liver transplantation for fulminant hepatic failure due to iatrogenic porta hepatis injury.

Guler N, Gunay Y, Dayangac M, Yaprak O, Akyildiz M, Yuzer Y, Tokat Y.

Minerva Chir. 2013 Jun;68(3):333-4. No abstract available.

PMID:
23774100
21.

Successful treatment of severe hepatorenal syndrome with living donor liver transplantation.

Demirbas BT, Piskin T, Dayangac M, Yaprak O, Oklu L, Yuzer Y, Tokat Y.

Hepatogastroenterology. 2012 Oct;59(119):2305-6. doi: 10.5754/hge10791.

PMID:
23435146
22.

Which incision is better for living-donor right hepatectomy? Midline, J-shaped, or Mercedes.

Demirbas T, Bulutcu F, Dayangac M, Yaprak O, Guler N, Oklu L, Akyildiz M, Altaca G, Tokat Y, Yuzer Y.

Transplant Proc. 2013 Jan-Feb;45(1):218-21. doi: 10.1016/j.transproceed.2012.06.081.

PMID:
23375303
23.

The Predictive and Prognostic Significance of c-erb-B2, EGFR, PTEN, mTOR, PI3K, p27, and ERCC1 Expression in Hepatocellular Carcinoma.

Bassullu N, Turkmen I, Dayangac M, Yagiz Korkmaz P, Yasar R, Akyildiz M, Yaprak O, Tokat Y, Yuzer Y, Bulbul Dogusoy G.

Hepat Mon. 2012 Oct;12(10 HCC):e7492. doi: 10.5812/hepatmon.7492. Epub 2012 Oct 11.

24.

A new technique for the reconstruction of complex portal vein anomalies in right lobe living liver donors.

Yaprak O, Guler N, Balci NC, Dayangac M, Demirbas T, Killi R, Tokat Y, Yuzer Y.

Hepatobiliary Pancreat Dis Int. 2012 Aug 15;11(4):438-41.

PMID:
22893474
25.

AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma.

Yaprak O, Akyildiz M, Dayangac M, Demirbas BT, Guler N, Dogusoy GB, Yuzer Y, Tokat Y.

Hepatobiliary Pancreat Dis Int. 2012 Jun;11(3):256-61.

PMID:
22672818
26.

Ratio of remnant to total liver volume or remnant to body weight: which one is more predictive on donor outcomes?

Yaprak O, Guler N, Altaca G, Dayangac M, Demirbas T, Akyildiz M, Ulusoy L, Tokat Y, Yuzer Y.

HPB (Oxford). 2012 Jul;14(7):476-82. doi: 10.1111/j.1477-2574.2012.00483.x.

27.

Vascular complications in hepatic transplantation: single-center experience in 14 years.

Akun E, Yaprak O, Killi R, Balci NC, Tokat Y, Yuzer Y.

Transplant Proc. 2012 Jun;44(5):1368-72. doi: 10.1016/j.transproceed.2012.02.027.

PMID:
22664017
28.

Living-donor liver transplant in 3 patients with Budd-Chiari syndrome: case report.

Bas K, Yaprak O, Dayangac M, Ulusoy OL, Dogusoy GB, Yuzer Y, Tokat Y.

Exp Clin Transplant. 2012 Apr;10(2):172-5. doi: 10.6002/ect.2011.0044. Epub 2012 Jan 25.

29.

Right-lobe liver transplant from donors with Gilbert syndrome.

Demirbas T, Piskin T, Dayangac M, Yaprak O, Akyildiz M, Tokat Y, Yuzer Y.

Exp Clin Transplant. 2012 Feb;10(1):39-42.

30.

International collaboration of Turkey in liver transplantation research: a bibliometric analysis.

Bas K, Dayangac M, Yaprak O, Yuzer Y, Tokat Y.

Transplant Proc. 2011 Dec;43(10):3796-801. doi: 10.1016/j.transproceed.2011.09.081. Epub 2011 Nov 10.

PMID:
22172849
31.

Biliary complications after right lobe living donor liver transplantation: a single-centre experience.

Yaprak O, Dayangac M, Akyildiz M, Demirbas T, Guler N, Bulutcu F, Bassullu N, Akun E, Yuzer Y, Tokat Y.

HPB (Oxford). 2012 Jan;14(1):49-53. doi: 10.1111/j.1477-2574.2011.00401.x. Epub 2011 Oct 25.

32.

Recipient splenic artery utilization for arterial re-anastomosis in living donor liver transplantation: single-center experience.

Piskin T, Demirbas T, Yalcin L, Yaprak O, Dayangac M, Guler N, Bulutcu F, Yuzer Y, Tokat Y.

Hepatogastroenterology. 2012 Jun;59(116):1263-4. doi: 10.5754/hge11642.

PMID:
22057376
33.

Living donor liver hilar variations: surgical approaches and implications.

Yaprak O, Demirbas T, Duran C, Dayangac M, Akyildiz M, Tokat Y, Yuzer Y.

Hepatobiliary Pancreat Dis Int. 2011 Oct;10(5):474-9.

PMID:
21947720
34.

General evaluation of hepatectomy and hepatocellular carcinoma cases.

Başsüllü N, Türkmen I, Yaprak O, Dayangaç M, Demırbaş T, Güler N, Uraz S, Akyildiz M, Cığercıoğullari E, Tokat Y, Yüzer Y, Doğusoy GB.

Turk Patoloji Derg. 2011;27(3):221-9. doi: 10.5146/tjpath.2011.01079.

35.

Cryopreserved aortic quilt plasty for one-step reconstruction of multiple hepatic venous drainage in right lobe living donor liver transplantation.

Yaprak O, Balci NC, Dayangac M, Demirbas T, Guler N, Ulusoy L, Tokat Y, Yuzer Y.

Transplant Proc. 2011 Sep;43(7):2817-9. doi: 10.1016/j.transproceed.2011.06.064.

PMID:
21911171
36.

Living donor liver transplantation for hepatocellular carcinoma: a single center analysis of outcomes and impact of different selection criteria.

Balci D, Dayangac M, Yaprak O, Akin B, Duran C, Killi R, Yuzer Y, Tokat Y.

Transpl Int. 2011 Nov;24(11):1075-83. doi: 10.1111/j.1432-2277.2011.01311.x. Epub 2011 Aug 19.

37.

Analysis of right lobe living-liver donor complications: a single center experience.

Yaprak O, Dayangac M, Demirbas BT, Tabendeh B, Yuzer Y, Tokat Y.

Exp Clin Transplant. 2011 Feb;9(1):56-9.

38.

Utilization of elderly donors in living donor liver transplantation: when more is less?

Dayangac M, Taner CB, Yaprak O, Demirbas T, Balci D, Duran C, Yuzer Y, Tokat Y.

Liver Transpl. 2011 May;17(5):548-55. doi: 10.1002/lt.22276.

39.

Use of livers from hepatitis B core antibody positive donors in living donor liver transplantation.

Yaprak O, Dayangac M, Balci D, Demirbas T, Yuzer Y, Tokat Y.

Hepatogastroenterology. 2010 Sep-Oct;57(102-103):1268-71.

PMID:
21410070
40.

Hepatitis B prophylaxis in living donor liver transplantation: single center experience.

Yaprak O, Dayangac M, Balci D, Bas K, Yuzer Y, Tokat Y.

Hepatogastroenterology. 2010 Sep-Oct;57(102-103):1178-82.

PMID:
21410054
41.

Dual left lobe living donor liver transplantation using donors unacceptable for right lobe donation: a case report.

Dayangac M, Taner CB, Akin B, Uraz S, Balci D, Duran C, Ayanoglu O, Killi R, Yuzer Y, Tokat Y.

Transplant Proc. 2010 Dec;42(10):4560-3. doi: 10.1016/j.transproceed.2010.09.149.

PMID:
21168737
42.

Characterization of frequency-dependent material properties of human liver and its pathologies using an impact hammer.

Umut Ozcan M, Ocal S, Basdogan C, Dogusoy G, Tokat Y.

Med Image Anal. 2011 Feb;15(1):45-52. doi: 10.1016/j.media.2010.06.010. Epub 2010 Jul 1.

PMID:
20655273
43.

Use of middle hepatic vein in right lobe living donor liver transplantation.

Dayangac M, Taner CB, Balci D, Memi I, Yaprak O, Akin B, Duran C, Killi R, Ayanoglu O, Yuzer Y, Tokat Y.

Transpl Int. 2010 Mar 1;23(3):285-91. doi: 10.1111/j.1432-2277.2009.00978.x. Epub 2009 Oct 12.

44.

Hepatic arterial mapping by multidetector computed tomographic angiography in living donor liver transplantation.

Duran C, Uraz S, Kantarci M, Ozturk E, Doganay S, Dayangac M, Bozkurt M, Yuzer Y, Tokat Y.

J Comput Assist Tomogr. 2009 Jul-Aug;33(4):618-25. doi: 10.1097/RCT.0b013e31818d814b.

PMID:
19638861
45.

Donor safety and remnant liver volume in living donor liver transplantation.

Taner CB, Dayangac M, Akin B, Balci D, Uraz S, Duran C, Killi R, Ayanoglu O, Yuzer Y, Tokat Y.

Liver Transpl. 2008 Aug;14(8):1174-9. doi: 10.1002/lt.21562.

46.

Splenic abscess after splenic artery ligation in living donor liver transplantation: a case report.

Balci D, Taner B, Dayangac M, Akin B, Yaprak O, Duran C, Uraz S, Hayzaran S, Ayanoglu O, Killi R, Senturk H, Yuzer Y, Tokat Y.

Transplant Proc. 2008 Jun;40(5):1786-8. doi: 10.1016/j.transproceed.2007.10.012.

PMID:
18589197
47.

The value of magnetic resonance cholangiography in the preoperative assessment of living liver donors.

Sirvanci M, Duran C, Ozturk E, Balci D, Dayangaç M, Onat L, Yüzer Y, Tokat Y, Killi R.

Clin Imaging. 2007 Nov-Dec;31(6):401-5.

PMID:
17996603
48.

Why we did not use this donor.

Duran C, Taner B, Dayangac M, Akin B, Balci D, Kurt Z, Killi R, Yuzer Y, Tokat Y.

Liver Transpl. 2007 Aug;13(8):1199-200. No abstract available.

49.

Urgent adult-to-adult right lobe living donor liver transplantation for acute liver failure; a single center experience from Turkey.

Karasu Z, Akyildiz M, Zeytunlu M, Noyan A, Yuzer Y, Tokat Y, Kilic M.

Hepatogastroenterology. 2007 Apr-May;54(75):810-3.

PMID:
17591069
50.

A very rare venous anomaly in a living liver donor: left hepatic venous connection to the right atrium.

Uraz S, Duran C, Balci D, Akin B, Dayangac M, Kurt Z, Ayanoglu OH, Killi R, Yuzer Y, Tokat Y.

Transplant Proc. 2007 Jun;39(5):1714-5.

PMID:
17580229

Supplemental Content

Support Center